CAS Medical Systems, Inc. (NASDAQ: CASM) develops and manufacturers medical devices for non-invasive patient monitoring. The company’s FORE-SIGHT Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation. Direct monitoring of tissue oxygenation provides a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues. For more information, visit the company’s website at www.casmed.com